The serum concentration of the receptor activator of nuclear factor-kB ligand (RANKL), osteoprotegerin (OPG) and lipids profile in children with nephrotic syndrome

被引：0
|
作者：
Panczyk-Tomaszewska, M. [1 ]
Ziolkowska, H. [1 ]
Adamczuk, D. [1 ]
Gorska, E. [2 ]
Stelmaszczyk-Emmel, A. [2 ]
Roszkowska-Blaim, M. [1 ]
机构：
[1] Med Univ Warsaw, Dept Pediat & Nephrol, Warsaw, Poland
[2] Med Univ Warsaw, Dept Lab Diagnost & Clin lmuunol Dev Age, Warsaw, Poland
来源：
BONE | 2009年 / 45卷
关键词：
D O I：
10.1016/j.bone.2009.04.121
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S86 / S86
页数：1
相关论文
共 50 条
  • [41] Osteoprotegerin and Ligand of Receptor Activator of Nuclear Factor
    Tan, Lijun
    Ren, Yijin
    Wang, Jun
    Jiang, Lingyong
    Cheng, Hui
    Sandham, Andrew
    Zhao, Zhihe
    ANGLE ORTHODONTIST, 2009, 79 (02) : 292 - 298
  • [42] Serum osteoprotegerin and receptor activator of nuclear factors kB (RANKL) concentrations in normal children and in children with pubertal precocity, Turner's syndrome and rheumatoid arthritis
    Buzi, F
    Maccarinelli, G
    Guaragni, B
    Ruggeri, F
    Radetti, G
    Meini, A
    Mazzolari, E
    Cocchi, D
    CLINICAL ENDOCRINOLOGY, 2004, 60 (01) : 87 - 91
  • [43] Receptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin levels in multiple sclerosis
    Kurban, Sevil
    Akpinar, Zehra
    Mehmetoglu, Idris
    MULTIPLE SCLEROSIS, 2008, 14 (03): : 431 - 432
  • [44] Relationship of endothelial function with serum osteoprotegerin (OPG) and receptor activator of nuclear factor kappa-B ligand (RANKL) in women with systemic lupus erythematosus (SLE).
    Rhew, Elisa Y.
    Lee, Chin
    Eksarko, Poli
    Chung, Anh
    Price, Heather E.
    Dyer, Alan R.
    Langman, Craig B.
    Pope, Richard M.
    McPherson, David D.
    Ramsey-Goldman, Rosalind
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S271 - S271
  • [45] Receptor activator NF κB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis
    Crotti, T
    Smith, MD
    Hirsch, R
    Soukoulis, S
    Weedon, H
    Capone, M
    Ahern, MJ
    Haynes, D
    JOURNAL OF PERIODONTAL RESEARCH, 2003, 38 (04) : 380 - 387
  • [46] Increases in bone turnover and the receptor activator of nuclear factor κB ligand (RANKL)/osteoprotegerin (OPG) ratio during high prolactin exposure
    Krishnamra, N.
    Seriwatanachai, D.
    Thongchote, K.
    Suthiphongchai, T.
    Charoenphandhu, N.
    BONE, 2007, 40 (06) : S210 - S211
  • [47] Imbalance of osteoprotegerin/receptor activator of nuclear factor-kB ligand in bone marrow plasma and microenvironment after allogeneic stem cell transplantation
    Selleri, C
    Tauchmanovà, L
    Ricci, P
    Risitano, AM
    Martorelli, MC
    Cerciello, G
    Imperatore, I
    Casale, A
    Musella, T
    Lombardi, G
    Colao, A
    Rotoli, B
    BONE MARROW TRANSPLANTATION, 2006, 37 : S309 - S309
  • [48] RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA-B LIGAND (RANKL) AND OSTEOPROTEGERIN (OPG) IN RADICULAR CYSTS, DENTIGEROUS CYSTS AND HEALTHY VOLUNTEERS
    Pechalova, Petia F.
    Poriazova, Elena G.
    Pavlov, Nikolai V.
    Gospodinov, Dimitar L.
    COMPTES RENDUS DE L ACADEMIE BULGARE DES SCIENCES, 2016, 69 (03): : 385 - 392
  • [49] Receptor Activator of Nuclear Transcription Factor NF-κB (RANK), Its Ligand RANKL, and Natural Inhibitor of RANKL Osteoprotegerin (OPG) in the Blood Serum of Patients with Primary Bone Tumors
    N. E. Kushlinskii
    E. S. Gershtein
    Yu. N. Solov’ev
    Yu. S. Timofeev
    I. V. Babkina
    A. O. Dolinkin
    A. A. Zuev
    O. I. Kostyleva
    Bulletin of Experimental Biology and Medicine, 2017, 163 : 478 - 481
  • [50] SERUM RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KB LIGAND (RANKL) AS BIOMARKER OF CHRONIC HEART FAILURE IN ELDERLY MALES
    Bozic, B.
    Loncar, G.
    Prodanovic, N.
    Cvorovic, V.
    Radojicic, Z.
    Dimkovic, S.
    Popovic-Brkic, V.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 32 - 32
12345